位置：成果数据库 > 期刊 > 期刊详情页
Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant c
  • 期刊名称：J Cell Mol Med. 2016 Feb 10. doi: 10.1111/jcmm.127
  • 时间：0
  • 页码：-
  • 相关项目：基于EGFR-TKI耐药相关生物学网络发现新靶标及克服耐药研究
作者： Jiannan Feng|Jizhen Lin|Yihua Zhang|Hui Peng|
同期刊论文项目
基于EGFR-TKI耐药相关生物学网络发现新靶标及克服耐药研究
期刊论文 24 会议论文 4
同项目期刊论文
艾洛替尼耐药的肝癌HepG2细胞株的建立及耐药机制研究
Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glyc
Bifendate-chalcone hybrids: A new class of potential dual inhibitors of P-glycoprotein and breast ca
Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multid
IGF-1R and ErbB3/HER3 Contribute to Enhanced Proliferation and Carcinogenesis in Trastuzumab-resista
Pharmacophore-based drug design and biological evaluation of novel ABCB1 inhibitors.
Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]
米哚妥林对P糖蛋白介导的多药耐药的逆转作用
艾洛替尼耐药的卵巢癌SKOV3细胞系的建立及其耐药特性
米哚妥林对P糖蛋白介导多药耐药的逆转作用
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resist
烷氧基联苯/姜黄素偶联物的合成及抗耐药肿瘤活性
瓦他拉尼对乳腺癌耐药蛋白介导的肿瘤多药耐药的逆转研究
细胞可塑性与肿瘤治疗耐药的研究进展
Discovery of alkoxyl biphenyl derivatives bearing dibenzo[c,e]azepine scaffold as potential dual inh
New use for an old drug: inhibiting ABCG2 with sorafenib.
艾洛替尼耐药肝癌HepG2细胞系的建立及其耐药机制
贝伐珠单抗促进小鼠结直肠癌肺转移的作用及可能机制
Network systems biology for targeted cancer therapies